OBJECTIVES: To evaluate changes over time in rates of bacterial vaginosis (BV), trichomoniasis (TV), and yeast vaginitis (YV) among HIV-infected and similar HIV-uninfected women. METHODS: Two thousand fifty-six HIV-infected women and 554 HIV-uninfected women were evaluated semiannually from 1994 until March 2003 in a prospective cohort study. BV was diagnosed by Gram stain, TV by wet mount, and YV by symptoms with microscopically visible hyphae or positive culture. Trends were assessed using Poisson models. RESULTS: At baseline, BV was present in 42.8% and 47.0% of HIV-infected and uninfected women (P = 0.21), TV in 6.1% and 7.8% (P = 0.17), and YV in 10.0% and 3.8% (P < 0.001). Over time, rates of BV and TV decreased significantly in both groups, whereas rates of YV declined only among HIV-infected women. Risk of BV was not associated with HIV status, whereas HIV-infected women had a lower risk of TV. Highly active antiretroviral therapy (HAART) use was associated with decreased risk of all 3 infections. CONCLUSIONS: : Declines in BV, TV, and YV represent decreased morbidity for HIV-infected women and, potentially, decreased risk of transmission of HIV, because each has been associated with increased genital detection of HIV.
OBJECTIVES: To evaluate changes over time in rates of bacterial vaginosis (BV), trichomoniasis (TV), and yeastvaginitis (YV) among HIV-infected and similar HIV-uninfectedwomen. METHODS: Two thousand fifty-six HIV-infectedwomen and 554 HIV-uninfectedwomen were evaluated semiannually from 1994 until March 2003 in a prospective cohort study. BV was diagnosed by Gram stain, TV by wet mount, and YV by symptoms with microscopically visible hyphae or positive culture. Trends were assessed using Poisson models. RESULTS: At baseline, BV was present in 42.8% and 47.0% of HIV-infected and uninfected women (P = 0.21), TV in 6.1% and 7.8% (P = 0.17), and YV in 10.0% and 3.8% (P < 0.001). Over time, rates of BV and TV decreased significantly in both groups, whereas rates of YV declined only among HIV-infectedwomen. Risk of BV was not associated with HIV status, whereas HIV-infectedwomen had a lower risk of TV. Highly active antiretroviral therapy (HAART) use was associated with decreased risk of all 3 infections. CONCLUSIONS: : Declines in BV, TV, and YV represent decreased morbidity for HIV-infectedwomen and, potentially, decreased risk of transmission of HIV, because each has been associated with increased genital detection of HIV.
Authors: Gregory T Spear; Douglas Gilbert; Alan L Landay; Reza Zariffard; Audrey L French; Pranjal Patel; Patrick M Gillevet Journal: Appl Environ Microbiol Date: 2010-11-12 Impact factor: 4.792
Authors: Megan Gatski; Leandro Mena; Judy Levison; Rebecca A Clark; Harold Henderson; Norine Schmidt; Susan L Rosenthal; David H Martin; Patricia Kissinger Journal: Sex Transm Dis Date: 2010-08 Impact factor: 2.830
Authors: Brooke E Hoots; Thomas A Peterman; Elizabeth A Torrone; Hillard Weinstock; Elissa Meites; Gail A Bolan Journal: Sex Transm Dis Date: 2013-02 Impact factor: 2.830
Authors: Danielle F Haley; Michael R Kramer; Adaora A Adimora; Regine Haardörfer; Gina M Wingood; Christina Ludema; Anna Rubtsova; DeMarc A Hickson; Zev Ross; Elizabeth Golub; Hector Bolivar; Hannah Lf Cooper Journal: Sex Transm Infect Date: 2017-03-07 Impact factor: 3.519
Authors: Leslie S Massad; Charlesnika T Evans; Raymond Kang; Anna Hotton; Ruth Greenblatt; Howard Minkoff; Kerry Murphy; Christine Colie; Kathleen M Weber Journal: AIDS Res Hum Retroviruses Date: 2016-12-16 Impact factor: 2.205
Authors: Danielle F Haley; Andrew Edmonds; Nadya Belenky; DeMarc A Hickson; Catalina Ramirez; Gina M Wingood; Hector Bolivar; Elizabeth Golub; Adaora A Adimora Journal: Sex Transm Dis Date: 2018-01 Impact factor: 2.830
Authors: Laura H Bachmann; Marcia M Hobbs; Arlene C Seña; Jack D Sobel; Jane R Schwebke; John N Krieger; R Scott McClelland; Kimberly A Workowski Journal: Clin Infect Dis Date: 2011-12 Impact factor: 9.079
Authors: Audrey L French; Oluwatoyin M Adeyemi; Denis M Agniel; Charlesnika T Evans; Michael T Yin; Kathryn Anastos; Mardge H Cohen Journal: J Womens Health (Larchmt) Date: 2011-08-29 Impact factor: 2.681